Femasys (FEMY) Revenue (2020 - 2025)

Femasys (FEMY) reported Revenue of $409268.0 for Q2 2025, up 84.78% on a YoY basis from $221484.0 in Q2 2024, and up 19.93% quarter-over-quarter from $341264.0 in Q1 2025.

Femasys (FEMY) Revenue (2020 - 2025) Analysis & Trends

Femasys has reported Revenue for 6 years, with the latest figure at $409268.0 in Q2 2025.

  • For the quarter ending Q2 2025, Revenue rose 84.78% year-over-year to $409268.0; the trailing twelve-month figure through Jun 2025 stood at $1.9 million (up 98.61% YoY), and the FY2025 full-year result was $2.3 million, up 40.77% from the prior year.
  • Revenue for Q2 2025 stood at $409268.0, up from $341264.0 in the prior quarter.
  • The five-year high for Revenue was $581576.0 in Q4 2024, with the low at $213111.0 in Q4 2023.
  • Historically, Revenue has averaged $324306.5 across 5 years, with a median of $311813.5 in 2022.
  • The largest YoY upside for Revenue was 172.9% in 2024 against a maximum downside of 30.9% in 2024.
  • Femasys' Revenue stood at $254327.0 in 2021, then decreased by 7.9% to $234244.0 in 2022, then slipped by 9.02% to $213111.0 in 2023, then soared by 172.9% to $581576.0 in 2024, then retreated by 29.63% to $409268.0 in 2025.
  • The last three Revenue figures came in at $409268.0 (Q2 2025), $341264.0 (Q1 2025), and $581576.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 2.77 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 4.71 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 7.35 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 1.43 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 844.90 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 2.01 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 1.08 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 1.04 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.70 Bn
10 Femasys 254.59 Mn 249.20 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 409,268.00
Mar 31, 2025 341,264.00
Dec 31, 2024 581,576.00
Sep 30, 2024 554,908.00
Jun 30, 2024 221,484.00
Mar 31, 2024 271,140.00
Dec 31, 2023 213,111.00
Sep 30, 2023 244,361.00
Jun 30, 2023 320,514.00
Mar 31, 2023 293,984.00
Dec 31, 2022 234,244.00
Sep 30, 2022 347,456.00
Jun 30, 2022 303,113.00
Mar 31, 2022 321,405.00
Dec 31, 2021 254,327.00
Sep 30, 2021 269,581.00
Jun 30, 2021 326,006.00
Mar 31, 2021 329,775.00
Dec 31, 2020 280,964.00
Sep 30, 2020 313,208.00